Ownership and Pay

Ownership and Pay

The Gerlach family's block is large, old and static: about 27.5% of the shares, roughly $30 million a year of dividend income at the current rate, and not one open-market purchase anywhere in the Form 4 record. The operating team's stake is grant-built — the CEO holds 0.21% of the company. Every financial measure in the incentive plans is sales, operating income or relative share performance; none is margin, cash flow or return on capital.

Who owns the company

Ownership above five percent is concentrated in one family and two index managers. John B. Gerlach, Jr. is shown at 7,510,191 shares, or 27.3% of the 27,547,758 shares outstanding at 22 September 2025; his mother, Dareth A. Gerlach, at 5,927,117 shares, or 21.5%; and the John B. Gerlach Trust A-1 at 5,737,602 shares, or 20.8% [1]. Those three lines overlap heavily. The Trust A-1 holding, and a further 137,430 shares in a 1974 taxable trust, appear in both Gerlach totals, so the family's combined non-overlapping position is 7,562,276 shares — 27.5% of the class. BlackRock is disclosed at 9.4% and Vanguard at 7.6%, both from 13G/A filings dated early 2024 [2].

Sources: 2025 Proxy Statement, beneficial-ownership tables [3] [4]; family total derived by removing the trust shares counted twice.

All executive officers and directors as a group — 14 people — hold 8,004,202 shares, 29.1% of the class. Within that, director Robert L. Fox holds 976,416 shares (3.5%), mostly through charitable foundations and a jointly-owned corporation. The CEO, David A. Ciesinski, holds 59,011 shares, 0.21% of the company [5].

Where the votes actually sit

The 27.3% headline overstates what the family's most visible member controls. The proxy footnote itemises his position, and most of it carries no voting or dispositive power for him at all: 5,737,602 shares in Trust A-1 and 137,430 in the 1974 taxable trust are held with Mr. Gerlach as trustee "with no power to vote or dispose of the shares," his mother serving as special trustee with sole power; a further 316,387 shares are his spouse's, with sole power held by her [6].

Source: 2025 Proxy Statement, footnote (2) to the beneficial-ownership table [7]; balance line derived as the residual.

On the proxy's own disclosure, 6,191,419 shares — 22.5% of the class — sit outside his voting and dispositive power. The sole power over the two trusts belongs to Dareth A. Gerlach, who is not a director and whose only appearance in the proxy is as a five-percent owner and as the mother of a director [8]. The block votes as a family bloc in practice; the point is that the disclosed decision right over the largest single holding rests with someone outside the boardroom, and the arrangements governing its succession are not in the public record.

The family's operating role ended some time ago. John B. Gerlach, Jr. has been a director since 1985 and was chief executive from 1997 to June 2017, then Executive Chairman until he retired from that post in December 2023 [9]. Marzetti is family-owned and professionally run, and the two facts point in different directions: the family's block decides the outcome of any shareholder vote while holding no executive role, and the operating team that sets strategy holds stakes built from grants rather than purchases.

What the block is paid

At the $1.00 quarterly rate now running [10], the family's 7,562,276 shares collect about $30.2 million a year, and the officers-and-directors group about $32.0 million, against a total dividend bill of roughly $110 million on the 27.4 million shares outstanding at 31 March 2026. The company has raised its regular dividend for 62 consecutive years through fiscal 2025 [11]. The largest holders are paid in dividends rather than in realised gains, and the streak is what protects that income.

Repurchases are the alternative use of that cash, and the record is thin. The share repurchase authorisation in force dates from November 2010; of the 2,000,000 shares approved then, 1,083,830 remained unused at 30 June 2025 — under half the authorisation consumed in fourteen and a half years [12].

Sources: Form 10-Q for the quarter ended 31 March 2026, statements of shareholders' equity [13] and cash flows [14]; average closing prices derived from daily market data.

The pattern inside fiscal 2026 is worth stating precisely. The company bought $20.1 million of stock in the December 2025 quarter — 123,000 shares, about $163 each — after buying only $8.0 million across the whole of fiscal 2025 [15]. It then bought $16,000 in the March 2026 quarter, a quarter in which the shares traded as low as $137.13 [16]. Dividends of $81.4 million were paid over the same nine months [17]. The obvious defence is timing rather than reluctance: the $20.1 million of buying fell in the December 2025 quarter, the Bachan's acquisition was announced on 3 February 2026, and the $16,000 quarter is the one in which cash was being held for a $400 million purchase. What the June quarter did is not yet disclosed; the fiscal 2026 Form 10-K had not been filed as at 29 July 2026.

Skin in the game, measured

Sources: 2025 Proxy Statement ownership tables [18] [19] and Summary Compensation Table [20]; dividend income derived at the $4.00 annualised rate.

The CEO's 59,011 shares are worth about $6.5 million at $110.19, against fiscal 2025 total compensation of $5.38 million [21]. The board requires him to hold six times base salary and reports that he meets it, with restricted stock counted toward the test [22]. That stake was built entirely from grants. Across the Form 4 record from 2019 to date, Mr. Ciesinski has sold 27,151 shares on the open market — 10,151 in November 2022 at around $209 and 17,000 on 13 February 2025 at $191.19 — and bought none.

Source: insider transaction filings (Forms 4 and 144) as filed with the SEC, 2019 to 29 July 2026 — every open-market purchase in the record. Structured filing data; no page-level PDF in this corpus.

Five open-market purchases in seven years, totalling about $1.2 million. Only one falls inside the de-rating: the chief financial officer bought 900 shares at $109.01 on 10 June 2026, $98,109, roughly 15% of his base salary. On the same two days the chief supply chain officer sold 1,221 shares at $109.31. No member of the Gerlach family has bought a share in the open market in the record; the family's only reported transactions are annual director stock grants and a single 2022 option exercise settled with the company.

Two housekeeping points sit alongside this. The proxy discloses two late Form 4 filings during fiscal 2025, one for the CEO and one for the incoming Retail president [23]. And the insider trading policy prohibits pledging shares as loan collateral and prohibits hedging outright [24] — which means no part of the family block sits behind margin debt.

What management is paid on

The annual plan is 75% financial and 25% personal. Within the financial part, adjusted operating income carries 70% and adjusted net sales 30% [25]. The long-term plan is 55% performance share units and 45% time-vested stock; the PSU half splits evenly between three-year net sales growth and relative total shareholder return against the S and P 1500 Packaged Foods and Meats Index [26]. The company's own list of the three most important measures used to determine pay is adjusted operating income, adjusted net sales and relative TSR [27].

Sources: 2025 Proxy Statement — annual incentive design and targets [28], fiscal 2025 results and payouts [29], long-term plan weightings [30] and fiscal 2023 PSU outcomes [31].

Nothing in that design charges management for capital. There is no margin metric, no cash-flow metric, no return-on-capital or per-share metric anywhere in the annual or the long-term plan. In a year in which the company committed $400 million to an acquisition at 4.6 times sales and drew a $200 million term loan against a previously debt-free balance sheet — the arithmetic is set out in Financials and Estimates — the incentive design registers the resulting revenue and, three years later, the resulting share price, but never the capital consumed to get there. It is also, on its own terms, an unusually direct wager on the sales engine examined in The Licensing Engine: 27.5% of long-term grant value pays on net sales growth alone.

The fiscal 2025 outcome shows the plan working as designed rather than generously. Adjusted net sales of $1,894.9 million came in at 98.8% of target and paid 81.0%; adjusted operating income of $229.2 million came in at 101.7% and paid 116.8%; the blended financial result was 106.1% of target [32]. Mr. Ciesinski's payout of $1,292,363 against a $1,219,000 target [33] is 106% of target, down from $1,520,404 in fiscal 2024 [34]. Two details cut in management's favour. The committee's adjusted net sales figure strips out the temporary supply agreement revenue — $14.2 million of the reported $1,909.1 million — so the plan did not pay on the one revenue line the filings describe as temporary [35]. And the relative-TSR PSU is capped at target if absolute three-year TSR is negative, regardless of relative ranking [36].

The fiscal 2023 PSUs vested in August 2025: relative TSR of 45.14% against an index return of 15.75% paid 186% of target, and adjusted net sales of $1,894.9 million against a $1,830.9 million goal paid 135% [37] [38]. That performance period closed on 30 June 2025, before the shares began falling; the fiscal 2025-2027 cycle now running spans the stall instead. The proxy discloses the target-setting convention for the earlier cycle — a 3.5% annual growth rate off the base year [39] but not the goals for the fiscal 2025-2027 grants. Applied to the fiscal 2024 base of $1,871.8 million, that convention implies a fiscal 2027 target near $2.08 billion, against consensus of $2.02 billion — a payout below target, on a derived figure that the company has not confirmed.

What a large inside stake does not buy

A 27.5% family block and a 29.1% insider group are usually read as alignment. Their more direct effect on outcomes is to foreclose a change of control. No unsolicited acquirer and no activist can carry a shareholder vote without the family, and the advance-notice provisions of the company's Code of Regulations, together with the 20 September 2026 deadline for a universal-proxy nomination notice, set the procedural cost of trying [40]. The route by which a de-rated packaged-food asset most often re-rates — someone buys it — is not available here on anything other than the family's terms.

That matters for how the pay design is policed. The 2024 say-on-pay vote drew 99.1% support [41], a figure in which the insider bloc is itself a large minority of the votes cast. Outside shareholders' influence over what management is measured on runs through a compensation committee that the same bloc helps elect.

The counter-case is real and should be weighed at the same time. The block is why the balance sheet carried no debt at all until April 2026, why the dividend has risen for sixty-two straight years, and why the borrowing taken for Bachan's was under one turn of EBITDA rather than three. The pay practices are clean by mid-cap standards: no repricing without shareholder approval [42], no tax gross-ups, no executive pension, double-trigger change-in-control vesting, a Rule 10D-1 clawback policy adopted in October 2023, an independent consultant, and payouts capped at 200% [43] [44]. An investor who wants the probability of financial distress close to zero is being served by exactly the ownership structure that also caps the ways the discount can close.

Pay against performance

The mandated pay-versus-performance table is the cleanest five-year record the company publishes of what shareholders and executives each received.

Source: 2025 Proxy Statement, Pay Versus Performance table [45]. Peer index is the S and P 1500 Packaged Foods and Meats Index; both indices are measured from 30 June 2020.

Two things stand out. The mechanism does bite: compensation actually paid to the CEO was negative $244,743 in fiscal 2022, when the shares fell, and $4.16 million in fiscal 2025 against $5.73 million the year before, as the change in fair value of unvested awards turned against him [46]. And the base rate is modest: $100 invested on 30 June 2020 was worth $122.70 five years later — 4.2% a year with dividends reinvested — while compensation actually paid to the CEO across those five years totalled $27.0 million and the tabled figure $23.9 million. The CEO-to-median-employee pay ratio for fiscal 2025 was 102 to 1, against median employee compensation of $52,692 [47].

The table stops at 30 June 2025, three days after the name change took effect [48] and about three months before the shares began falling. Extending it on the same basis — the closing price of $110.19 on 28 July 2026 and the $3.95 of dividends paid since the fiscal year end — the $100 is worth roughly $81.

Sources: 2025 Proxy Statement, Pay Versus Performance table, for the fiscal 2021-2025 points [49]; the July 2026 point is derived from the closing price of $110.19 on 28 July 2026 and dividends declared since the fiscal 2025 year end, and no peer figure is available for that date.

The fiscal 2025-2027 PSU cycle, granted in August 2024, was priced off a grant-date fair value of $193.39 for the net-sales tranche and $221.61 for the relative-TSR tranche, with the restricted stock granted alongside it cliff-vesting on 13 August 2027 [50]. The next cycle was granted in August 2025, when the CEO's associated tax-withholding transactions were struck at $180.29. At $110.19 the operating team holds a large amount of paper worth roughly half what it was booked at, which is the alignment the plan was designed to produce and is now producing.

Directors

Non-employee directors received $135,000 of restricted stock plus cash fees in fiscal 2025, with totals ranging from $212,491 to $329,991 — except for John B. Gerlach, Jr., at $745,159. The difference is $535,170 of "perquisites and other personal benefits" that the proxy attributes to business-related professional and filing fees and to payment of deferred compensation and accrued interest [51]. That is the settlement of a deferred balance accumulated over three decades as an executive rather than current-year director pay, and it should be read as such. The same table discloses that committee fees had gone unpaid after a 2017 change in board compensation structure [52]; the narrative below it names four directors, and dates the discovery to December 2024 and the corrective payment to January 2025 [53]. Eight of the ten directors are independent under Nasdaq standards, and the chair and chief executive roles are separate, with Alan F. Harris as chairman [54].

The read, and what would change it

On the evidence here: ownership is concentrated but passive, and pay is competently governed but pointed at the wrong end of the problem. The family's economic interest is realised as dividend income rather than as a re-rating, which is consistent with a fourteen-year-old repurchase authorisation still less than half used and with $20 million of buying done at $163 and none done at $137. Management's incentives run on sales, operating income and relative share performance, so a strategy of buying growth at high multiples registers in the numerator of every plan metric and never in the denominator.

The strongest fact against that reading is the pay-versus-performance record itself: compensation actually paid went negative in fiscal 2022 and fell 27% in fiscal 2025, the relative-TSR tranche is capped at target whenever absolute returns are negative, and roughly half the CEO's outstanding equity is currently marked well below grant. The design does transmit shareholder losses to the executive, with a lag of up to three years.

Three things would move the read. A material step-up in repurchases at prices near the current level, disclosed in the fiscal 2026 Form 10-K, would show the board treating the de-rating as an opportunity rather than a constraint. An open-market purchase by a member of the family, absent from the entire Form 4 record, would say more than any governance disclosure. And the addition of a cash-flow or return-on-capital measure to the fiscal 2027 incentive design — the proxy confirms the fiscal 2026 plan was left unchanged [55] — would indicate that the board has priced the change in the company's capital structure into how it pays for growth.